GAMMA Investing’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$518K Buy
14,637
+2,172
+17% +$64.2K 0.02% 637
2026
Q1
$345K Buy
12,465
+1,426
+13% +$36.6K 0.02% 762
2025
Q4
$240K Buy
11,039
+1,737
+19% +$34.3K 0.01% 908
2025
Q3
$141K Buy
9,302
+1,324
+17% +$16.4K 0.01% 1218
2025
Q2
$89.9K Buy
7,978
+1,485
+23% +$16.1K 0.01% 1535
2025
Q1
$65.5K Buy
6,493
+2,945
+83% +$31.8K ﹤0.01% 1594
2024
Q4
$42K Buy
3,548
+1,288
+57% +$15.2K ﹤0.01% 1793
2024
Q3
$26.1K Buy
2,260
+167
+8% +$1.9K ﹤0.01% 1946
2024
Q2
$22.1K Buy
2,093
+836
+67% +$9.16K ﹤0.01% 1789
2024
Q1
$13.2K Buy
1,257
+116
+10% +$1.25K ﹤0.01% 1895
2023
Q4
$11.4K Buy
+1,141
New +$11.1K ﹤0.01% 1836

Other funds holding ROIV